{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:55:57Z","timestamp":1776329757868,"version":"3.50.1"},"reference-count":15,"publisher":"Baskent University","issue":"Suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.6002\/ect.mesot2023.p65","type":"journal-issue","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T08:02:35Z","timestamp":1708070555000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"22","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Mieli-Vergani G, Vergani D, Czaja AJ, et al. Autoimmune hepatitis. Nat Rev Dis Primers. 2018;4:18017. doi:10.1038\/nrdp.2018.17","DOI":"10.1038\/nrdp.2018.17"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Gleeson D, Heneghan MA, British Society of G. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut. 2011;60(12):1611-1629. doi:10.1136\/gut.2010.235259","DOI":"10.1136\/gut.2010.235259"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Adam R, Karam V, Delvart V, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol. 2012;57(3):675-688. doi:10.1016\/j.jhep.2012.04.015","DOI":"10.1016\/j.jhep.2012.04.015"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193-2213. doi:10.1002\/hep.23584","DOI":"10.1002\/hep.23584"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020;72(2):671-722. doi:10.1002\/hep.31065","DOI":"10.1002\/hep.31065"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Martin SR, Alvarez F, Anand R, Song C, Yin W, Group SR. Outcomes in children who underwent transplantation for autoimmune hepatitis. Liver Transpl. 2011;17(4):393-401. doi:10.1002\/lt.22244","DOI":"10.1002\/lt.22244"},{"key":"ref6","unstructured":"7. Saberifiroozi M, Serati AR, Malekhosseini SA, et al. Analysis of patients listed for liver transplantation in Shiraz, Iran. Indian J Gastroenterol. 2006;25(1):11-13."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Shafiei M, Alavian SM. Autoimmune hepatitis in Iran: what we know, what we don't know and requirements for better management. Hepat Mon. 2012;12(2):73-76. doi:10.5812\/hepatmon.840","DOI":"10.5812\/hepatmon.840"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Krawitt EL. Clinical features and management of autoimmune hepatitis. World J Gastroenterol. 2008;14(21):3301-3305. doi:10.3748\/wjg.14.3301","DOI":"10.3748\/wjg.14.3301"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Hayashi M, Keeffe EB, Krams SM, et al. Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg. 1998;4(3):208-214. doi:10.1002\/lt.500040313","DOI":"10.1002\/lt.500040313"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Edmunds C, Ekong UD. Autoimmune liver disease post-liver transplantation: a summary and proposed areas for future research. Transplantation. 2016;100(3):515-524. doi:10.1097\/TP.0000000000000922","DOI":"10.1097\/TP.0000000000000922"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Harputluoglu M, Caliskan AR, Akbulut S. Autoimmune hepatitis and liver transplantation: indications, and recurrent and de novo autoimmune hepatitis. World J Transplant. 2022;12(3):59-64. doi:10.5500\/wjt.v12.i3.59","DOI":"10.5500\/wjt.v12.i3.59"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. de Quadros Onofrio F, Neong E, Adebayo D, et al. Single-center North American experience of liver transplantation in autoimmune hepatitis: infrequent indication but good outcomes for patients. J Can Assoc Gastroenterol. 2020;4(3):137-144. doi:10.1093\/jcag\/gwaa022","DOI":"10.1093\/jcag\/gwaa022"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Kerkar N, Yanni G. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: a comprehensive review. J Autoimmun. 2016;66:17-24. doi:10.1016\/j.jaut.2015.08.017","DOI":"10.1016\/j.jaut.2015.08.017"},{"key":"ref14","unstructured":""}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T03:00:17Z","timestamp":1708311617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2024\/22\/1\/1\/247\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":15,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2023.p65","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}